| #44 |
Reza Oboodi |
Honeywell |
1 |
| #44 |
Vijaya Juturu |
Omniactive Health Technologies Limited |
1 |
| #44 |
Qi Bi |
AT&T |
1 |
| #44 |
Saul Jaime-Figueroa |
Yale University |
1 |
| #44 |
Geoff Keiser |
ExxonMobil |
1 |
| #44 |
John Wong |
Sony |
1 |
| #44 |
Christopher Modin |
Marotta Controls |
1 |
| #44 |
Richard Hatley |
GE |
1 |
| #44 |
John V. Facinelli |
Advansix Resins & Chemicals |
1 |
| #44 |
Naofal Al-Dhahir |
AT&T |
1 |
| #44 |
Robert M. Harris |
Fmc |
1 |
| #44 |
Stephen Deems Gabriel |
Hoffmann-La Roche |
1 |
| #44 |
Matthew Stark |
Spectranetics |
1 |
| #44 |
Srinivas Meda |
S&P Global |
1 |
| #44 |
Marios Hadjieleftheriou |
AT&T |
1 |
| #44 |
Martin R. Paonessa |
Honeywell |
1 |
| #44 |
Abhijit BHATTACHARYA |
Omniactive Health Technologies Limited |
1 |
| #44 |
Keith Johnson |
Endeca Technologies |
1 |
| #44 |
Stephen Whittaker |
AT&T |
1 |
| #44 |
Munroe Chirnomas |
— |
1 |
| #44 |
James Pace |
AT&T |
1 |
| #44 |
Jennifer Yates |
AT&T |
1 |
| #44 |
Gina Eagle |
Insmed Incorporated |
1 |
| #44 |
Matti Hiltunen |
AT&T |
1 |
| #44 |
Justyna Dudaronek |
Becton, Dickinson And |
1 |
| #44 |
Vivek Kumar Rangarajan Sridhar |
— |
1 |
| #44 |
Alice Yuan Bain |
Cellco Partnership |
1 |
| #44 |
Brandon Eble |
Robert Bosch Gmbh |
1 |
| #44 |
Amanda M. Stagg |
Avon Products |
1 |
| #44 |
MeiHsiu Lin |
The Dun & Bradstreet |
1 |
| #44 |
Qian Zheng |
Avon Products |
1 |
| #44 |
Manjusha Mehendale |
Rudolph Technologies |
1 |
| #44 |
Robert Fox |
Haworth |
1 |
| #44 |
Karyn B. Visscher |
Isp Investments |
1 |
| #44 |
Kimo Jepsen |
— |
1 |
| #44 |
Todd Bill |
Honeywell |
1 |
| #44 |
Michael S. Ackerman |
— |
1 |
| #44 |
Andrew Roberts |
Bank of America |
1 |
| #44 |
Lynn Haynes |
— |
1 |
| #44 |
Parag Shah |
Mallinckrodt Hospital Products Ip Unlimited |
1 |
| #44 |
Stephen M. Slater |
Shukla Medical |
1 |
| #44 |
Mark John Lindsey |
Sun Chemical |
1 |
| #44 |
Steven Faiello |
Specified Technologies |
1 |
| #44 |
Matthew Morrison |
Becton, Dickinson And |
1 |
| #44 |
Kishor Kabse |
Intercontinental Great Brands |
1 |
| #44 |
Dawn Bell |
Chiesi Farmaceutici S.P.A. |
1 |
| #44 |
Mario C. Baldassari |
Lummus Technology |
1 |
| #44 |
Thomas S. Tighe |
Trw Limited |
1 |
| #44 |
Isaac Ghebre-Sellassie |
Warner-Lambert Company |
1 |
| #44 |
Chris Janow |
Omnitek Partners |
1 |